My Medication Side Effects Are Too Popular

This means that the nature of the equity of Sun Pharmaceutical has changed.

No longer Asan's company

If not, why should Asan's political axe protect you?

It is impossible for foreign-funded enterprises to obtain the compulsory patent license granted by Asan.

That is to say, since Sun Pharmaceutical was acquired by Pfizer, many generic drugs are no longer legal!

Although Sun Pharmaceutical also has some truly authorized patent licenses, other pharmaceutical companies will not continue to license at this time, and the previous license contracts

There are also many pitfalls

Sun Pharma used to be a rogue, or even Asan's pharmaceutical companies were like this, and pharmaceutical companies in other countries couldn't do anything about it.

But now that Sun Pharmaceutical has changed its boss, it is much easier to sue Pfizer.

The lawsuit can also not be on Asan's side, but on the United States' side

On the US side, if you don't abide by the patent law, it will affect the interests of other companies. They don't care who your Pfizer shareholders are!

If the first company starts a lawsuit, there are others who follow suit.

In less than three days, Pfizer received more than [-] patent lawsuits!

Some claims are extremely high. Maybe Pfizer will only need to pay a small amount in the end, but it will also make Pfizer bear a large amount of legal fees and seriously affect them.

's reputation.

Now it is impossible for Pfizer to give up Sun Pharmaceutical. It has already acquired it. How can those top pharmaceutical companies easily let Pfizer go?

Everyone's profits are falling this year, and if they can bite a piece of meat from Pfizer, of course they have to seize the opportunity!

Fu Liang watched the news that Pfizer was rushing to hire a team of lawyers.

Originally, there are many lawyer teams in these large enterprises, which are generally sufficient.

But this time it is really not enough. More than [-] lawsuits, many of which are being held at the same time, and their directors of Pfizer are not enough!

They're now trying to coordinate and stagger court times a little bit, but even so, Pfizer's directors are all getting a headache

After the news came out, Pfizer's stock price, which had risen because of the acquisition of Sun Pharmaceutical, began to fall rapidly again.

It fell by [-]% in less than a day. This is the result of Pfizer's shareholders' efforts to stabilize the stock price.

Unfortunately, when the market opened the next day, the stock price continued to fall.

In just three days, Pfizer's stock price fell [-] percent,

This time, it did not cause a decline in global pharmaceutical stocks, but Huirui's own stock price could not be stabilized.

Some Yu Rong institutions once again smelled fishy sharks and took a bite at Pfizer.

Even if you only fry for a week, you can still make a lot of money

Pfizer is finished, this time, at least Pfizer will not be able to recover for more than a year

When the competition among global pharmaceutical companies is so fierce, Pfizer has been delayed for a year, and if they want to come back strongly, unless they can develop some new special drugs, they have to

The effect is amazing.

If Pfizer had the ability, it would have done so long ago.

Will it be pulled from the first throne?

After this time, Pfizer may not even be able to maintain its position in the top ten or even the top twenty in the world.

Except for Fu Liang's side, Johnson & Johnson is the most excited.

Previously, Pfizer vigorously developed the generic drug business, and even acquired some generic drug companies. Sales and profits rose again, threatening Johnson & Johnson.

Qiang Niu knows that he won't be sitting on the throne for long, but at least it will be more than a year, right?

You can't go up for a quarter or two for a short period of time and then be pulled down.

It's not easy for Xinming Pharmaceutical to overtake a strong cow. Biyin Xinming Pharmaceutical Research and Development Laboratory has no affiliation with Xinming Pharmaceutical.

The profit margin of Xinming Pharmaceutical is not so high.

In addition, many new special medicines (bbdc) have not yet been listed, and the sales are also supported by Shengfaling and Lung Pain Clearing. There is no possibility of surpassing Johnson & Johnson within a year.

No matter what, Johnson & Johnson also has other businesses such as nursing products and nutritional products. In addition to the pharmaceutical business, the annual sales of [-] to [-] billion US dollars are easily.

According to Johnson & Johnson's estimates, it will not really take the throne of the world's No. [-] pharmaceutical company until Xinming Pharmaceutical has ten new drugs with special effects on the market.

That's still relying on sales exceeding. In terms of net profit, Johnson & Johnson will not lose to Xinming Pharmaceutical, but will lose to Fu Liang early.

Now Pfizer is at a disadvantage again, and Johnson & Johnson is taking the lead in attacking Pfizer.

At the same time, pharmaceutical companies such as Roche and Baidou did not hesitate.

The chairman of Johnson & Johnson specially called to thank Fu Liang: "Mr. Xiao Fu, this time Pfizer is finished, they have delayed for a year or two, and they want to get up again.

Absolutely impossible, other pharmaceutical companies will not give him a chance.

"Sofutin will be available soon, and I can guarantee that we, Johnson & Johnson, will push this painkiller in the global market, making it the number one prescription painkiller.

If you choose, the market share will definitely exceed [-]%!

The reason why I dare not say [-]% is that some old prescription painkillers are cheaper, and when they are not used frequently, there will still be-

Some patients choose the cheaper ones.

Painkillers, Pfizer was the best seller in the world, and then Johnson & Johnson.

Now Johnson & Johnson has invested in the drug, and cooperated to develop it.

Although the shareholding ratio is a little less, it will definitely make a profit.

It is not guaranteed for more than a year, the sales of more than [-] billion US dollars are easy, and the profit is definitely more than [-]%!

This investment is also one of Johnson & Johnson's most successful investments.

Invest [-] billion dollars, and in the next [-] years, you will definitely get tens of billions of dollars, or even more

Although this return on investment may not be comparable to those special new drugs that Johnson & Johnson has invested in before.

- a strong competitor

And they also helped Xinming Pharmaceutical to quickly expand its sales channels and cultivated a

But they do not cooperate, other pharmaceutical companies will cooperate

Until then, the strong bull is the passive passive!

Fu Liang said with a smile: "Okay, then I'm looking forward to Johnson & Johnson's sales capabilities.

This time, Jiantongting has been listed in nearly [-] countries around the world at the same time, and it is also the first drug developed by Fu Liang to be marketed on a large scale.

He also wanted to see what surprises Johnson could give him this time.

Half a month later, Xinqiang Pharmaceutical held a grand press conference.

At the meeting, Fu Xinming solemnly announced: "The special painkiller Sudeng Stop will be launched simultaneously in more than [-] countries around the world in three days!

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!

Chapter [-]: One day to create sales records

Amid the long-awaited calls for many patients, Sutongdai is finally on the market.

The price of this drug is not high. It is 108 a pill in China and 19 dollars a pill abroad, which is not much difference.

Although Supain is not a life-saving drug, it is a commonly used drug

Whether it is surgical pain relief or other pain relief, the effect is very ~ very good.

The annual global market for painkillers exceeds US$[-] billion, of which about [-]% are over-the-counter painkillers-drugs

For example, ibuprofen and the like, this kind not only can relieve pain, but also reduce fever.

The remaining [-]% or so are prescription painkillers, of which opioids dominate.

But opioids are highly regulated in many countries because of their addictive nature.

There are many people who are obviously in pain, but are reluctant to use opioids for pain relief, because they are afraid of addiction, a serious and high-incidence side effect.

This problem can be solved after the rapid pain stop appears.

, many people went to the hospital to register and prescribe medicine, mostly women and the elderly.

On the first day of the listing of Sutong,

"You give me a quick stop. My shoulders, joints, and lumbar spine are always in pain.

- An old man went in and looked directly at the doctor:

Sometimes I can't sleep.

The doctor looked at the old man: "Master, you can't rely on painkillers for pain, you have to check it to see what's wrong, and prescribe the right medicine.

"Otherwise, the pain is temporarily relieved, and it will still be painful in the future.

The old man looked at the doctor: "I have some rheumatoid arthritis and a little lumbar disc herniation. I have seen it, and the doctor prescribed a lot of medicines, which are not good.

"I just want it to be less painful, anyway, these diseases are not life-threatening, it doesn't matter if they are cured or not.

"Usually I can still hold it up, just take some ibuprofen. If it rains on a cloudy day, I can't increase the amount. Can you give me some quick pain to stop the pain?

The doctor dropped the old man's case, and then began to write the doctor's order in the medical record book.

"Master, this medicine is more expensive, one hundred and eighty tablets, depending on your weight, it's not a problem for one tablet to last for twelve hours, if you want to feel no pain for a day

That's two slices.

"How much do you want to drive? Do you have enough money?

"Enough, I brought the card, you give me a hundred pieces first!